Perspective Therapeutics
CATX
#8140
Rank
NZ$0.34 B
Marketcap
$5.04
Share price
0.35%
Change (1 day)
-16.56%
Change (1 year)

Revenue for Perspective Therapeutics (CATX)

Revenue in 2024 (TTM): -NZ$8.29 Million

According to Perspective Therapeutics's latest financial reports the company's current revenue (TTM ) is -NZ$9.26 Million. In 2023 the company made a revenue of -NZ$8.29 Million.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Perspective Therapeutics from 2002 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) -NZ$8.29 Million-0%
2023 -NZ$8.29 Million
2021 NZ$15.65 M14.04%
2020 NZ$13.72 M10.44%
2019 NZ$12.42 M25.49%
2018 NZ$9.9 M30.25%
2017 NZ$7.6 M18.92%
2016 NZ$6.39 M-11.59%
2015 NZ$7.23 M35.16%
2014 NZ$5.34 M-5.03%
2013 NZ$5.63 M-0.58%
2012 NZ$5.66 M-13.45%
2011 NZ$6.54 M-1.18%
2010 NZ$6.62 M-9.54%
2009 NZ$7.32 M-33.5%
2008 NZ$11.01 M22.04%
2007 NZ$9.02 M70.14%
2006 NZ$5.3 M
2004 N/A
2003 N/A
2002 N/A